--- title: "12 Health Care Stocks Moving In Tuesday's Pre-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/296226815.md" description: "In Tuesday's pre-market session, healthcare stocks showed mixed movements. Amylyx Pharmaceuticals surged 27.5% to $27.32, while bioAffinity Technologies rose 25.28%. Other gainers included China SXT Pharmaceuticals and YD Bio. Conversely, DocGo fell 16.2%, Apimeds Pharmaceuticals dropped 12.39%, and Jin Medical International declined 11.28%. These fluctuations occurred ahead of regular market hours." datetime: "2026-08-18T12:06:16.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296226815.md) - [en](https://longbridge.com/en/news/296226815.md) - [zh-HK](https://longbridge.com/zh-HK/news/296226815.md) generator: "portal-rs" --- # 12 Health Care Stocks Moving In Tuesday's Pre-Market Session ### Gainers - **Amylyx Pharmaceuticals** (NASDAQ:AMLX) stock increased by 27.5% to $27.32 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.3 billion. - **bioAffinity Technologies** (NASDAQ:BIAF) shares increased by 25.28% to $0.49. The company's market cap stands at $3.1 million. - **China SXT Pharmaceuticals** (NASDAQ:SXTC) stock moved upwards by 22.93% to $4.61. The market value of their outstanding shares is at $2.0 million. - **YD Bio** (NASDAQ:YDES) shares increased by 15.13% to $3.88. The company's market cap stands at $238.7 million. - **Apollomics** (NASDAQ:APLM) stock increased by 11.25% to $26.2. The market value of their outstanding shares is at $68.2 million. - **Haemonetics** (NYSE:HAE) stock moved upwards by 10.74% to $99.97. The company's market cap stands at $4.1 billion. ### Losers - **DocGo** (NASDAQ:DCGO) stock fell 16.2% to $0.59 during Tuesday's pre-market session. The market value of their outstanding shares is at $70.1 million. The company's, Q2 earnings came out yesterday. - **Apimeds Pharmaceuticals** (AMEX:APUS) stock decreased by 12.39% to $3.75. The market value of their outstanding shares is at $6.4 million. As per the news, the Q2 earnings report came out 2 days ago. - **Jin Medical International** (NASDAQ:ZJYL) stock declined by 11.28% to $3.07. The company's market cap stands at $27.0 million. - **Psyence Biomedical** (NASDAQ:PBM) shares fell 10.81% to $3.22. The company's market cap stands at $13.7 million. - **Modular Medical** (NASDAQ:MODD) shares decreased by 8.02% to $2.18. The market value of their outstanding shares is at $12.8 million. The company's, Q1 earnings came out 2 days ago. - **Pomdoctor** (NASDAQ:POM) stock decreased by 7.98% to $0.81. The market value of their outstanding shares is at $104.3 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [YDES.US](https://longbridge.com/en/quote/YDES.US.md) - [AMLX.US](https://longbridge.com/en/quote/AMLX.US.md) - [BIAF.US](https://longbridge.com/en/quote/BIAF.US.md) - [ZJYL.US](https://longbridge.com/en/quote/ZJYL.US.md) - [SXTC.US](https://longbridge.com/en/quote/SXTC.US.md) - [BIAFW.US](https://longbridge.com/en/quote/BIAFW.US.md) - [DCGO.US](https://longbridge.com/en/quote/DCGO.US.md) - [APUS.US](https://longbridge.com/en/quote/APUS.US.md) - [APLM.US](https://longbridge.com/en/quote/APLM.US.md) - [HAE.US](https://longbridge.com/en/quote/HAE.US.md) - [PBM.US](https://longbridge.com/en/quote/PBM.US.md) - [MODD.US](https://longbridge.com/en/quote/MODD.US.md) - [POM.US](https://longbridge.com/en/quote/POM.US.md) - [YDESW.US](https://longbridge.com/en/quote/YDESW.US.md) - [APLMW.US](https://longbridge.com/en/quote/APLMW.US.md) - [PBMWW.US](https://longbridge.com/en/quote/PBMWW.US.md) ## Related News & Research - [DocGo Announces Upcoming Participation at Morgan Stanley 24th Annual Global Healthcare Conference | DCGO Stock News](https://longbridge.com/en/news/297645979.md) - [YD Bio CEO Ethan Shen acquires 18,378 shares valued at $67,246.26](https://longbridge.com/en/news/298359096.md) - [Jin Medical agrees US$159.42 million VIE control deal for Huaxia Qiying assets](https://longbridge.com/en/news/298366003.md) - [Amylyx Pharmaceuticals to present at Morgan Stanley Global Healthcare Conference](https://longbridge.com/en/news/298323815.md) - [Amylyx signs Bachem manufacturing deal for avexitide supply starting 2028](https://longbridge.com/en/news/298364899.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**